• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY PROMUS PREMIER¿; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY PROMUS PREMIER¿; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Model Number H7493952824350
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Intimal Dissection (1333); Ventricular Tachycardia (2132)
Event Date 06/07/2015
Event Type  Injury  
Event Description
(b)(4).It was reported that vessel dissection occurred.In (b)(6) 2015, the patient presented with an anterior wall st elevation myocardial infarction (stemi) and underwent an emergent percutaneous coronary intervention (pci).There were 2 target lesions and no non-target lesions.Target lesion #1 was a de novo lesion located in the proximal right coronary artery (rca) with 95% stenosis.It was 20mm long, with a reference vessel diameter of 3.5mm with mild calcification.It was the culprit lesion for the stemi.The lesion was not predilated and a 3.50 x 28mm promus premier¿ stent was implanted resulting to 0% residual stenosis.Post dilation was performed and the patient¿s pain was resolved with improved ecg reading.Target lesion #2 was a de novo lesion located in the second obtuse marginal (om) with 95% stenosis.It was 20mm long, with a reference vessel diameter of 3.5mm with moderate calcification and moderate vessel tortuosity.Target lesion #2 was treated with predilation using a 3.0mm in diameter balloon catheter at 14 atmospheres.Then a 3.50x24mm promus premier¿ stent was advanced but could not be delivered due to the degree of calcification and tortuosity of the lesion.Use of a buddy wire and a non bsc guide extension catheter were also unsuccessful.The physician switched to a non bsc catheter and easily rewired the vessel.Then with some difficulty, the stent was delivered and was deployed at nominal pressure with good results.During insertion of the stent, there appeared to be either a small edge grade a dissection or a pseudo-stenosis from the wire proximal to the stent.The most severe dissection was located proximal to the target lesion, which required an implantation of a 3.50 x 12mm promus premier¿ stent in an overlapping manner.Post dilation was performed using a 3.5mm in diameter balloon catheter at 11 atmospheres.Post insertion of the two stents, the residual stenosis was 0% with a timi 3 flow.Angiographic results were excellent and the patient was pain-free.The event was considered to be resolved on the same day.One day post procedure, there was an asymptomatic, non-sustained 15 beat wide-complex tachycardia, consistent with non-sustained ventricular tachycardia, which was treated with oral potassium.Subsequently, frequent premature ventricular contractions (pvcs) were noted, but no further episodes of ventricular tachycardia occurred.Two days post procedure, the patient was discharged on aspirin and brilinta (ticagrelor).
 
Manufacturer Narrative
(b)(4).Device is a combination product.Device evaluated by mfr: the complaint device was not returned for analysis.The manufacturing batch record review confirmed that the device met all material, assembly and performance specifications.The root cause is anticipated procedural complications as this event is a known physiological effect of the procedure and is noted within the dfu.(b)(4).
 
Manufacturer Narrative
(b)(4).
 
Event Description
It was further reported that the physician attributed the non- sustained ventricular tachycardia and premature ventricular contractions to myocardial infarction upon admission and low potassium.The patient was not placed on an anti-arrhythmic agent.There was no relationship of these events to the implantation of the 3.50 x 28mm and the 3.50x24mm promus premier¿ stents.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS PREMIER¿
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
ballybrit business park
galway
Manufacturer (Section G)
BOSTON SCIENTIFIC - GALWAY
ballybrit business park
galway
Manufacturer Contact
linda leimer
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key4920056
MDR Text Key6011616
Report Number2134265-2015-04466
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P110010
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,Health Professional,Company Representative,company representati
Reporter Occupation Other
Type of Report Initial
Report Date 06/17/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date06/05/2016
Device Model NumberH7493952824350
Device Catalogue Number39528-2435
Device Lot Number17601562
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 06/17/2015
Initial Date FDA Received07/16/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/25/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age65 YR
-
-